Stability-indicating HPLC assay and solution stability of a new diaziridinyl benzoquinone

RH1, 3-methyl-6-hydroxymethyl-2,5-diaziridinyl-1,4-benzoquinone, is a NQO1 (NAD(P)H quinone oxidoreductase) directed anti-tumor agent. It is designed as a water soluble analog of MeDZQ (3,6-dimethyl-2,5-diaziridinyl-1,4-benzoquinone) and is ii drug candidate for clinical evaluation. A HPLC assay has been developed for its analysis. The assay is sensitive (1dl < 0.2 ng), precise (rsd < 1%), linear (r(2) = 0.9997), accurate (error < 0.6%), and stability-indicating. Using the developed assay, aqueous stability of RH1 has been evaluated. Both aziridine rings in MeDZQ are known to be easily hydrolyzable in aqueous solutions, however, hydrolysis of the second aziridine ring in RH1 appears inhibited. (C) 2001 Elsevier Science B.V. All rights reserved.